Dystroglycan is a transmembrane receptor protein that provides a structural linkage between extracellular matrix components and cytoskeletal proteins. It was originally characterized as a member of dystrophin associated protein complex in muscle but, unlike other proteins of this complex, mutations in the dystroglycan gene have not been implicated as a cause of muscular dystrophies. Indeed, dystroglycan is an essential gene, expressed early in development that, if removed in knockout mice, provokes lethal defects before the onset of myogenesis. Dystroglycan is synthesized as a precursor propeptide that is post-translationally cleaved and glycosylated to yield alpha and beta subunits. We have cloned and characterized a cDNA clone, containing the complete coding region of the dystroglycan precursor, from a Xenopus laevis cDNA library. We have performed a spatial and temporal analysis of its expression in X. laevis embryos, using whole-mount in situ hybridization and reverse transcription-polymerase chain reaction analysis. Early expression of dystroglycan in a variety of tissues of different embryological derivation suggests a crucial role in morphogenetic events, especially during central nervous system differentiation. q
Results
Search in NCBI-EST GenBank for dystroglycan homologs in Xenopus laevis provided two EST clones (acc. no. BE506803 and BG037666) showing considerable homology to 5 0 and 3 0 extremities of the human dystroglycan coding region (acc. no. L19711). We designed specific primers to isolate the complete coding region of dystroglycan from a stage 28/30 X. laevis head cDNA library, using polymerase chain reaction amplification. Sequence analysis of a 2661 bases cDNA fragment revealed a 886 amino acids long putative protein that shares high homology with human dystroglycan. In particular, the percentage of identity is 95% in the cytoplasmic and transmembrane regions of the beta subunits, 56% in the extracellular region of beta and 60% in the alpha subunits, respectively. A comparison between Xenopus dystroglycan sequence and those of human (L19711.1), mouse (AAH07150.1), bovine (BAA23650.1) and rabbit (X64393.1), is shown in Fig. 1 . The highest homology among different species is always found in the beta-subunits, confirming the biological relevance of this region. The cleavage site (Ser), the potential membrane targeting signals and the N and O-linked glycosylation sites are identical to those proposed in the human homolog (Deyst et al., 1995; Smalheiser and Kim, 1995; Holt et al., 2000) (Fig. 1) . More recently the sequence of zebrafish dystroglycan has been cloned (Parsons et al., 2002) . The percentage of identity is 96% in the cytoplasmic and transmembrane regions of the beta subunits, 36% in the extracellular region of the beta subunits and 56% in the alpha subunits, respectively. Temporal expression of X-dystroglycan mRNA (X-dg) during early X. laevis embryogenesis was revealed by reverse transcription-polymerase chain reaction (RT-PCR) analysis. X-dg is present in embryos as a maternal transcript; zygotic expression persists in all the analyzed stages (Fig. 2) .
Spatial expression pattern was also analyzed using wholemount in situ hybridization and subsequent histological sections. The earliest expression of X-dg is detectable in early neurula stage embryos (st. 13) in the anterior half of the midline (Fig. 3A) . At midneurula stage (st. 15) X-dg expression is present in the neural plate, where the neurogenic cells orient medio-laterally to participate in neural tube formation, and in the notochord, as revealed by sections (data not shown). A diffuse and punctate expression Blue dots indicate two group of residues that have been suggested to be a targeting motif for basolateral surface of epithelial cells (Kachinsky et al., 1999) .
is also detectable in the epidermal ectoderm (Figs. 3B,C). At late neurula stage (st. 19) a strong expression site is localized in presumptive prosencephalic/mesencephalic region ( Fig. 3D, arrowhead) . Note the absence of expression in the region from which neural crest cells derive (Fig. 3E , dorsal view). During neural tube closure (st. 22), X-dg transcripts are clearly detectable in prosencephalon evaginations of the eye anlagen, in rhomboencephalon ( Fig. 3F , arrowhead) and in the otic vescicle primordium (Fig. 3G , arrowhead). X-dg epidermal ectoderm expression is not present in the most anterior part of the embryo ( Fig. 3G ) and is limited to the sensorial layer of this tissue, as revealed by sections of this stage embryos (Figs. 3J,K). At early tail bud stage (st. 26) Xdg epidermal ectoderm signal disappears, while the expression remains concentrated in prosencephalon, mesencephalon, in a restricted anterior area of the rhomboencephalon and in the dorsomedian portion of eye vesicles, representing the prospective pigmented layer of the retina (Fig. 3H,  arrowhead) . Finally, at stage 33, X-dg transcripts are present in several tissues derived from different germ layers (Fig.  3I) . Enlarged view of the dorsal trunk musculature shows dystroglycan expression at level of myotomes (Fig. 3L) . On the other hand, using a cross-reacting antibody raised against human dystroglycan, we have detected immunoreactivity only at level of the transverse myosepta at this stage (Fig. 3M, arrowheads) . A similar phenotype has been recently observed also in zebrafish embryos (Parsons et al., 2002) . In the adult skeletal muscle the protein has specific sarcolemma localization, as already reported in human and mouse muscles (Fig. 3N) .
Serial transverse sections of stage 33 embryos from anterior to posterior revealed high expression in the olfactory placode (op), in the telencephalic ventricular zone (Fig. 4A) , in the diencephalic ventricular region and in the stomodeum (Fig. 4B, arrowhead) . In contrast, in the most posterior portion of the diencephalon X-dg expression is limited to the dorsal aspect (Fig. 4C ). Furthermore, high signal level is detectable in the epiphysis (ep), hypotalamus (hyp), optic lobe of the mesencephalon (Fig. 4E ) and in the dorsal rhomboencephalon (Fig. 4F ). In the eye, X-dg is expressed in the ganglion cell layer (gcl) of the neural retina ( Fig. 4G ) and at level of the optic stalk (os) (Fig. 4H) . Neural X-dg expression was further analyzed during early metamorphosis stage (st. 48) by whole-mount in situ hybridization of dissected brains (Fig. 5) . This procedure allows to distinguish with more details X-dg specific transcripts, in particular in the ventral territories, where expression is limited to the optic chiasma, hypothalamus, pituitary gland and olfactory bulb.
Cloning of the Xenopus dystroglycan coding region allowed a detailed analysis of its expression during embryogenesis. In particular, our analysis revealed for the first time a dynamic pattern of X-dg expression at level of central nervous system that suggests a direct involvement in differentiation of specific structures. A crucial role of dystroglycan in branching epithelial morphogenesis (Durbeej and Ekblom, 1997; Henry and Campbell, 1998) and in muscle differentiation (Brown et al., 1999; Leschziner et al., 2000) has been previously demonstrated. On the other hand, owing to the inability to generate viable dystroglycan-null mice, because of lethal defects in early basal membrane formation, the role of dystroglycan in neuronal cell differentiation has remained elusive (Williamson et al., 1997) . Recently Moore et al. made 'conditional' knockout mice, where dystroglycan expression was inactivated in glia and brain neurons only. These mutants have brain malformations, such as disarray of cerebral cortical layering, aberrant migration of granule cells that resemble specific human congenital brain dystrophies (Moore et al., 2002) and give new insight into the role of dystroglycan in neuronal development (Ross, 2002) . In contrast, complete removal of dystroglycan in zebrafish embryos causes loss of muscle integrity and necrosis, but not embryo lethality (Parsons et al., 2002) .
The characterization of the coding region and the expression pattern of Xenopus dystroglycan, presented in this paper, opens the possibility to design specific tools to perturb dystroglycan function and to test its role during morphogenetic events.
Methods

Xenopus dystroglycan cloning
Two EST cDNA clones were obtained from IMAGE Consortium and sequenced to confirm and to complete the sequences derived from the NCBI-EST data. The clone BE50680 contains 50 bp of 5 0 untranslated region followed by the first 318 nucleotides of the coding region. The complete sequence of clone BG037666 revealed that it contains the last 600 bp of the coding region and 1168 bp of 3 0 untranslated region, followed by a poly ( 
RT-PCR analysis
RT-PCR analysis was performed using total RNA isolated from embryos at the indicated stages and the SuperScript 
In situ hybridization
Whole-mount in situ hybridization on X. leavis embryos was performed as described (Harland, 1991) , except that BM purple (Roche) was used as a substrate for the alkaline phosphatase, using a X-dg antisense cRNA 600 bases long. Non-specific hybridization of X-dg riboprobe was evaluated with the corresponding X-dg sense probe. Histological examinations were performed as described in Pannese et al. (1998) . Bleaching of pigmented embryos was done after colour reaction as described (Mayor et al., 1995) .
Immunohistochemistry
Dissected muscle and embryos were immersion-fixed for 1 h at 4 8C in 4% paraformaldehyde in 100 mM phosphate buffer pH 7.4, then cryoprotected by immersion in 25% sucrose in PBS overnight at 4 8C. Tissues were frozen in freezing medium (OCT compound; Sakura Finetek Europe B.V.), sectioned vertically at 12 mm thickness in a cryostat, collected on slides (SuperFrost Plus; Menzel-Glaser, Germany), air dried for 30 min, and stored at 280 8C until use. Immunohistochemistry labeling: blocking in PBS pH 7.4 containing 10% normal goat serum, 1% bovine serum albumine and 0.05% Triton X-100, sections were incubated with primary monoclonal antibody (43DAG/ 8D5, Novocastra) in PBS supplemented with 3% NGS and 0.05% Triton X-100 for 60 min at room temperature and then with secondary goat anti-mouse antibody coupled to rodamine-isothiocyanate (TRITC; Sigma T7657) or to peroxidase (HRP; Sigma A2304), using 3,3 0 diaminobenzidine (DAB; Sigma D4293) substrate.
